Views & Analysis The future of healthcare: the patient advocate and investor ... Examining the views of different stakeholders in the ecosystem supporting drug R&D.
Views & Analysis Tunnah’s musings: Hope over hype for pharma in patient centr... Three areas where the pharma industry will advance in 2017 as it looks beyond the hype.
Views & Analysis Why you need a better online strategy for black box products Black box warnings need not impede sales if products are supported by carefully-researched online marketing strategies.
Articles Hooray for patient engagement teams Patient advocate Andrew Schorr welcomes pharma's efforts to listen to, and work with, patients and calls for company-wide support for these new initiatives.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.